Transgene SA
PAR:TNG

Watchlist Manager
Transgene SA Logo
Transgene SA
PAR:TNG
Watchlist
Price: 0.946 EUR -5.02%
Market Cap: 125.1m EUR

Wall Street
Price Targets

TNG Price Targets Summary
Transgene SA

Wall Street analysts forecast TNG stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

Lowest
Price Target
1.414 EUR
49% Upside
Average
Price Target
1.734 EUR
83% Upside
Highest
Price Target
2.1 EUR
122% Upside
Transgene SA Competitors:
Price Targets
300122
Chongqing Zhifei Biological Products Co Ltd
39% Upside
HUMA
Humacyte Inc
271% Upside
1530
3SBio Inc
5% Upside
ADMA
ADMA Biologics Inc
46% Upside
BCRX
BioCryst Pharmaceuticals Inc
61% Upside
300841
Chengdu Kanghua Biological Products Co Ltd
39% Upside
GMAB
Genmab A/S
42% Upside
600201
Jinyu Bio-Technology Co Ltd
11% Upside

Revenue
Forecast

Revenue Estimate
Transgene SA

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 19%.

-3%
Past Growth
19%
Estimated Growth
Estimates Accuracy
-10%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Net Income
Forecast

Net Income Estimate
Transgene SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-52%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is TNG's stock price target?
Price Target
1.734 EUR

According to Wall Street analysts, the average 1-year price target for TNG is 1.734 EUR with a low forecast of 1.414 EUR and a high forecast of 2.1 EUR.

What is Transgene SA's Revenue forecast?
Projected CAGR
19%

For the last 8 years the compound annual growth rate for Transgene SA's revenue is -3%. The projected CAGR for the next 4 years is 19%.

Back to Top